Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/156921
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Bolaños, Juan P. | - |
dc.date.accessioned | 2017-10-31T10:25:43Z | - |
dc.date.available | 2017-10-31T10:25:43Z | - |
dc.date.issued | 2016 | - |
dc.identifier | doi: 10.1111/jnc.13486 | - |
dc.identifier | e-issn: 1471-4159 | - |
dc.identifier | issn: 0022-3042 | - |
dc.identifier.citation | Journal of Neurochemistry 139(S2): 115-125 (2016) | - |
dc.identifier.uri | http://hdl.handle.net/10261/156921 | - |
dc.description.abstract | Neuronal activity is a high-energy demanding process recruiting all neural cells that adapt their metabolism to sustain the energy and redox balance of neurons. During neurotransmission, synaptic cleft glutamate activates its receptors in neurons and in astrocytes, before being taken up by astrocytes through energy costly transporters. In astrocytes, the energy requirement for glutamate influx is likely to be met by glycolysis. To enable this, astrocytes are constitutively glycolytic, robustly expressing 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3), an enzyme that is negligibly present in neurons by continuous degradation because of the ubiquitin-proteasome pathway via anaphase-promoting complex/cyclosome (APC)-Cdh1. Additional factors contributing to the glycolytic frame of astrocytes may include 5′-AMP-activated protein kinase (AMPK), hypoxia-inducible factor-1 (HIF-1), pyruvate kinase muscle isoform-2 (PKM2), pyruvate dehydrogenase kinase-4 (PDK4), lactate dehydrogenase-B, or monocarboxylate transporter-4 (MCT4). Neurotransmission-associated messengers, such as nitric oxide or ammonium, stimulate lactate release from astrocytes. Astrocyte-derived glycolytic lactate thus sustains the energy needs of neurons, which in contrast to astrocytes mainly rely on oxidative phosphorylation. Neuronal activity unavoidably triggers reactive oxygen species, but the antioxidant defense of neurons is weak; hence, they use glucose for oxidation through the pentose-phosphate pathway to preserve the redox status. Furthermore, neural activity is coupled with erythroid-derived erythroid-derived 2-like 2 (Nrf2) mediated transcriptional activation of antioxidant genes in astrocytes, which boost the de novo glutathione biosynthesis in neighbor neurons. Thus, the bioenergetics and redox programs of astrocytes are adapted to sustain neuronal activity and survival. Developing therapeutic strategies to interfere with these pathways may be useful to combat neurological diseases. | - |
dc.description.sponsorship | J.P.B. is funded by the MINECO (SAF2013‐41177‐R; RTC‐2015‐3237‐1), the Instituto de Salud Carlos III (RD12/0043/0021), the E.U. SP3‐People‐MC‐ITN programme (608381), the E.U. BATCure grant (666918), the European Regional Development Fund, and the NIH/NIDA (1R21DA037678‐01). | - |
dc.publisher | John Wiley & Sons | - |
dc.publisher | International Society for Neurochemistry | - |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/666918 | - |
dc.relation | info:eu-repo/grantAgreement/EC/FP7/608381 | - |
dc.relation | info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2013‐41177‐R | - |
dc.relation | info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/RTC‐2015‐3237‐1 | - |
dc.relation.isversionof | Publisher's version | - |
dc.rights | openAccess | - |
dc.subject | AMPK | - |
dc.subject | Cdh1 | - |
dc.subject | Glycolysis | - |
dc.subject | GSH | - |
dc.subject | Nrf2 | - |
dc.subject | PFKFB3 | - |
dc.title | Bioenergetics and redox adaptations of astrocytes to neuronal activity | - |
dc.type | artículo | - |
dc.identifier.doi | 10.1111/jnc.13486 | - |
dc.relation.publisherversion | https://doi.org/10.1111/jnc.13486 | - |
dc.date.updated | 2017-10-31T10:25:43Z | - |
dc.description.version | Peer Reviewed | - |
dc.language.rfc3066 | eng | - |
dc.rights.license | http://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
dc.contributor.funder | European Commission | - |
dc.contributor.funder | Instituto de Salud Carlos III | - |
dc.contributor.funder | National Institutes of Health (US) | - |
dc.contributor.funder | Ministerio de Economía y Competitividad (España) | - |
dc.relation.csic | Sí | - |
dc.identifier.funder | http://dx.doi.org/10.13039/501100000780 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100004587 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/100000002 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100003329 | es_ES |
dc.identifier.pmid | 26968531 | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | open | - |
item.openairetype | artículo | - |
item.fulltext | With Fulltext | - |
Aparece en las colecciones: | (IBFG) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
redoxastrocytes.pdf | 394,12 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
77
checked on 24-abr-2024
SCOPUSTM
Citations
183
checked on 06-may-2024
WEB OF SCIENCETM
Citations
175
checked on 26-feb-2024
Page view(s)
247
checked on 06-may-2024
Download(s)
334
checked on 06-may-2024